跳轉至內容
Merck
全部照片(1)

重要文件

RPMI 6666

87081807, human blood, Lymphoblast

登入查看組織和合約定價


About This Item

分類程式碼代碼:
41106514
生物源:
human blood
增長模式:
Suspension
染色體組型:
2n = 46
形態學:
Lymphoblast
產品:
Immunoglobulin
受體:
Not specified
相關疾病:
cancer

產品名稱

RPMI 6666, 87081807

生物源

human blood

增長模式

Suspension

染色體組型

2n = 46

形態學

Lymphoblast

產品

Immunoglobulin

受體

Not specified

技術

cell culture | mammalian: suitable

相關疾病

cancer

運輸包裝

dry ice

儲存溫度

−196°C

細胞系來源

Human Caucasian lymphoblast, Hodgkins disease

細胞系描述

Derived from a 29 year old male Caucasian with Hodgkin′s disease. One of a large series of permanent lines from leukocytes in the peripheral blood of donors with and without malignancies. Has cell-associated EBV and produces immunoglobulins. This cell line was initially thought to have been derived from Hodgkin lymphoma, but is now known to be an EBV-positive B-lymphoblastoid cell line.

應用

Tumourigenicity studies

培養基

RPMI 1640 + 2mM Glutamine + 20% Foetal Bovine Serum (FBS).

例行更新培養

Maintain cultures between 3-9x100,000 cells/ml; 5% CO2; 37°C.

其他說明

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

抱歉,我們目前沒有在線上提供本產品的COA

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務